Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Segersvärd R[au]:

Early detection and prevention of pancreatic cancer: is it really possible today? Del Chiaro M et al. World J Gastroenterol. (2014)

Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer. Meng Q et al. J Immunother. (2016)

European experts consensus statement on cystic tumours of the pancreas. Del Chiaro M et al. Dig Liver Dis. (2013)

Search results

Items: 1 to 50 of 57

1.

Radiological assessment of local resectability status in patients with pancreatic cancer: Interreader agreement and reader performance in two different classification systems.

Loizou L, Duran CV, Axelsson E, Andersson M, Keussen I, Strinnholm J, Bartholomä W, Del Chiaro M, Segersvärd R, Lundell L, Kartalis N.

Eur J Radiol. 2018 Sep;106:69-76. doi: 10.1016/j.ejrad.2018.06.014. Epub 2018 Jun 20.

PMID:
30150053
2.

RCAN1 is a marker of oxidative stress, induced in acute pancreatitis.

Norberg KJ, Nania S, Li X, Gao H, Szatmary P, Segersvärd R, Haas S, Wagman A, Arnelo U, Sutton R, Heuchel RL, Löhr JM.

Pancreatology. 2018 Oct;18(7):734-741. doi: 10.1016/j.pan.2018.08.005. Epub 2018 Aug 16.

PMID:
30139658
3.

First results from the Swedish National Pancreatic and Periampullary Cancer Registry.

Tingstedt B, Andersson B, Jönsson C, Formichov V, Bratlie SO, Öhman M, Karlsson BM, Ansorge C, Segersvärd R, Gasslander T.

HPB (Oxford). 2019 Jan;21(1):34-42. doi: 10.1016/j.hpb.2018.06.1811. Epub 2018 Aug 7.

PMID:
30097413
4.

Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer.

Del Chiaro M, Rangelova E, Halimi A, Ateeb Z, Scandavini C, Valente R, Segersvärd R, Arnelo U, Verbeke CS.

HPB (Oxford). 2018 Aug 6. pii: S1365-182X(18)32704-7. doi: 10.1016/j.hpb.2018.07.017. [Epub ahead of print]

PMID:
30093144
5.

Development and Feasibility of an Interactive Smartphone App for Early Assessment and Management of Symptoms Following Pancreaticoduodenectomy.

Gustavell T, Langius-Eklöf A, Wengström Y, Segersvärd R, Sundberg K.

Cancer Nurs. 2018 Mar 27. doi: 10.1097/NCC.0000000000000584. [Epub ahead of print]

PMID:
29596113
6.

Pancreatectomies for pancreatic neoplasms in pediatric and adolescent age: A single institution experience.

Scandavini C, Valente R, Rangelova E, Segersvärd R, Arnelo U, Permert J, Svensson PJ, Stenman J, Del Chiaro M.

Pancreatology. 2018 Mar;18(2):204-207. doi: 10.1016/j.pan.2017.12.009. Epub 2017 Dec 19.

PMID:
29277262
7.

A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients With Pancreatic Cancer.

Omazic B, Ayoglu B, Löhr M, Segersvärd R, Verbeke C, Magalhaes I, Potacova Z, Mattsson J, Terman A, Ghazi S, Albiin N, Kartalis N, Nilsson P, Poiret T, Zhenjiang L, Heuchel R, Schwenk JM, Permert J, Maeurer MJ, Ringden O.

J Immunother. 2017 Mar 23. doi: 10.1097/CJI.0000000000000164. [Epub ahead of print]

PMID:
28338506
8.

Symptoms and self-care following pancreaticoduodenectomy: Perspectives from patients and healthcare professionals - Foundation for an interactive ICT application.

Gustavell T, Sundberg K, Frank C, Wengström Y, Browall M, Segersvärd R, Langius-Eklöf A.

Eur J Oncol Nurs. 2017 Feb;26:36-41. doi: 10.1016/j.ejon.2016.12.002. Epub 2016 Dec 13.

PMID:
28069150
9.

Survival Analysis and Risk for Progression of Intraductal Papillary Mucinous Neoplasia of the Pancreas (IPMN) Under Surveillance: A Single-Institution Experience.

Del Chiaro M, Ateeb Z, Hansson MR, Rangelova E, Segersvärd R, Kartalis N, Ansorge C, Löhr MJ, Arnelo U, Verbeke C.

Ann Surg Oncol. 2017 Apr;24(4):1120-1126. doi: 10.1245/s10434-016-5661-x. Epub 2016 Nov 7.

10.

Are there still indications for total pancreatectomy?

Del Chiaro M, Rangelova E, Segersvärd R, Arnelo U.

Updates Surg. 2016 Sep;68(3):257-263. Epub 2016 Sep 7. Review.

11.

Cattell-Braasch maneuver combined with local hypothermia during superior mesenteric artery resection in pancreatectomy.

Westermark S, Rangelova E, Ansorge C, Lundell L, Segersvärd R, Del Chiaro M.

Langenbecks Arch Surg. 2016 Dec;401(8):1241-1247. Epub 2016 Aug 25.

12.

Leakage of albumin in major abdominal surgery.

Norberg Å, Rooyackers O, Segersvärd R, Wernerman J.

Crit Care. 2016 Apr 26;20(1):113. doi: 10.1186/s13054-016-1283-8.

13.

Multidetector CT of pancreatic ductal adenocarcinoma: Effect of tube voltage and iodine load on tumour conspicuity and image quality.

Loizou L, Albiin N, Leidner B, Axelsson E, Fischer MA, Grigoriadis A, Del Chiaro M, Segersvärd R, Verbeke C, Sundin A, Kartalis N.

Eur Radiol. 2016 Nov;26(11):4021-4029. Epub 2016 Mar 10.

PMID:
26965503
14.

Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.

Meng Q, Liu Z, Rangelova E, Poiret T, Ambati A, Rane L, Xie S, Verbeke C, Dodoo E, Del Chiaro M, Löhr M, Segersvärd R, Maeurer MJ.

J Immunother. 2016 Feb-Mar;39(2):81-9. doi: 10.1097/CJI.0000000000000111.

PMID:
26849077
15.

Outcome of probe-based confocal laser endomicroscopy (pCLE) during endoscopic retrograde cholangiopancreatography: A single-center prospective study in 45 patients.

Löhr JM, Lönnebro R, Stigliano S, Haas SL, Swahn F, Enochsson L, Noel R, Segersvärd R, Del Chiaro M, Verbeke CS, Arnelo U.

United European Gastroenterol J. 2015 Dec;3(6):551-60. doi: 10.1177/2050640615579806.

16.

Cattell-Braasch Maneuver Combined with Artery-First Approach for Superior Mesenteric-Portal Vein Resection During Pancreatectomy.

Del Chiaro M, Segersvärd R, Rangelova E, Coppola A, Scandavini CM, Ansorge C, Verbeke C, Blomberg J.

J Gastrointest Surg. 2015 Dec;19(12):2264-8. doi: 10.1007/s11605-015-2958-1. Epub 2015 Sep 30.

PMID:
26423804
17.

Variant Profiling of Candidate Genes in Pancreatic Ductal Adenocarcinoma.

Huang J, Löhr JM, Nilsson M, Segersvärd R, Matsson H, Verbeke C, Heuchel R, Kere J, Iafrate AJ, Zheng Z, Ye W.

Clin Chem. 2015 Nov;61(11):1408-16. doi: 10.1373/clinchem.2015.238543. Epub 2015 Sep 16.

18.

Albumin Kinetics in Patients Undergoing Major Abdominal Surgery.

Norberg Å, Rooyackers O, Segersvärd R, Wernerman J.

PLoS One. 2015 Aug 27;10(8):e0136371. doi: 10.1371/journal.pone.0136371. eCollection 2015.

19.

Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas).

Jais B, Rebours V, Malleo G, Salvia R, Fontana M, Maggino L, Bassi C, Manfredi R, Moran R, Lennon AM, Zaheer A, Wolfgang C, Hruban R, Marchegiani G, Fernández Del Castillo C, Brugge W, Ha Y, Kim MH, Oh D, Hirai I, Kimura W, Jang JY, Kim SW, Jung W, Kang H, Song SY, Kang CM, Lee WJ, Crippa S, Falconi M, Gomatos I, Neoptolemos J, Milanetto AC, Sperti C, Ricci C, Casadei R, Bissolati M, Balzano G, Frigerio I, Girelli R, Delhaye M, Bernier B, Wang H, Jang KT, Song DH, Huggett MT, Oppong KW, Pererva L, Kopchak KV, Del Chiaro M, Segersvard R, Lee LS, Conwell D, Osvaldt A, Campos V, Aguero Garcete G, Napoleon B, Matsumoto I, Shinzeki M, Bolado F, Fernandez JM, Keane MG, Pereira SP, Acuna IA, Vaquero EC, Angiolini MR, Zerbi A, Tang J, Leong RW, Faccinetto A, Morana G, Petrone MC, Arcidiacono PG, Moon JH, Choi HJ, Gill RS, Pavey D, Ouaïssi M, Sastre B, Spandre M, De Angelis CG, Rios-Vives MA, Concepcion-Martin M, Ikeura T, Okazaki K, Frulloni L, Messina O, Lévy P.

Gut. 2016 Feb;65(2):305-12. doi: 10.1136/gutjnl-2015-309638. Epub 2015 Jun 4.

PMID:
26045140
20.

Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.

Del Chiaro M, Verbeke CS, Kartalis N, Pozzi Mucelli R, Gustafsson P, Hansson J, Haas SL, Segersvärd R, Andren-Sandberg Å, Löhr JM.

JAMA Surg. 2015 Jun;150(6):512-8. doi: 10.1001/jamasurg.2014.3852.

PMID:
25853369
21.

Pancreas-preserving duodenectomy is a safe alternative to high-risk pancreatoduodenectomy for premalignant duodenal lesions.

Rangelova E, Blomberg J, Ansorge C, Lundell L, Segersvärd R, Del Chiaro M.

J Gastrointest Surg. 2015 Mar;19(3):492-7. doi: 10.1007/s11605-014-2738-3. Epub 2015 Jan 7.

PMID:
25564323
22.

Association between pancreatic intraductal papillary mucinous neoplasms and extrapancreatic malignancies.

Marchegiani G, Malleo G, D'Haese JG, Wenzel P, Keskin M, Pugliese L, Borin A, Benning V, Nilsson L, Oruc N, Segersvard R, Friess H, Schmid R, Löhr M, Maisonneuve P, Bassi C, Ceyhan GO, Salvia R, Del Chiaro M.

Clin Gastroenterol Hepatol. 2015 Jun;13(6):1162-9. doi: 10.1016/j.cgh.2014.11.029. Epub 2014 Dec 2.

PMID:
25478920
23.

The use of LigaSure™ Does not Affect Histologic Margin Assessment in Pancreatoduodenectomy (PD) specimens.

Del Chiaro M, Blomberg J, Segersvärd R, Rangelova E, Ansorge C, Verbeke C.

JOP. 2014 Nov 28;15(6):597-9. doi: 10.6092/1590-8577/2856.

24.

Single-operator pancreatoscopy is helpful in the evaluation of suspected intraductal papillary mucinous neoplasms (IPMN).

Arnelo U, Siiki A, Swahn F, Segersvärd R, Enochsson L, del Chiaro M, Lundell L, Verbeke CS, Löhr JM.

Pancreatology. 2014 Nov-Dec;14(6):510-4. doi: 10.1016/j.pan.2014.08.007. Epub 2014 Sep 27.

PMID:
25287157
25.

Early detection and prevention of pancreatic cancer: is it really possible today?

Del Chiaro M, Segersvärd R, Lohr M, Verbeke C.

World J Gastroenterol. 2014 Sep 14;20(34):12118-31. doi: 10.3748/wjg.v20.i34.12118. Review.

26.

Innovations in pancreatic surgery.

Hirota M, Sand J, Segersvärd R, Cirocchi R.

Biomed Res Int. 2014;2014:963416. doi: 10.1155/2014/963416. Epub 2014 Jul 21. No abstract available.

27.

The state of the art of robotic pancreatectomy.

Del Chiaro M, Segersvärd R.

Biomed Res Int. 2014;2014:920492. doi: 10.1155/2014/920492. Epub 2014 May 28. Review.

28.

Correlation between preoperative imaging and intraoperative risk assessment in the prediction of postoperative pancreatic fistula following pancreatoduodenectomy.

Frozanpor F, Loizou L, Ansorge C, Lundell L, Albiin N, Segersvärd R.

World J Surg. 2014 Sep;38(9):2422-9. doi: 10.1007/s00268-014-2556-5.

PMID:
24711156
29.

Assessing surgical quality: comparison of general and procedure-specific morbidity estimation models for the risk adjustment of pancreaticoduodenectomy outcomes.

Ansorge C, Lindström P, Strömmer L, Blomberg J, Lundell L, Andrén-Sandberg A, Del Chiaro M, Segersvärd R.

World J Surg. 2014 Sep;38(9):2412-21. doi: 10.1007/s00268-014-2554-7.

PMID:
24705780
30.

Comparison of preoperative conference-based diagnosis with histology of cystic tumors of the pancreas.

Del Chiaro M, Segersvärd R, Pozzi Mucelli R, Rangelova E, Kartalis N, Ansorge C, Arnelo U, Blomberg J, Löhr M, Verbeke C.

Ann Surg Oncol. 2014 May;21(5):1539-44. doi: 10.1245/s10434-013-3465-9. Epub 2014 Jan 3.

PMID:
24385209
31.

Is intraductal tubulopapillary neoplasia a new entity in the spectrum of familial pancreatic cancer syndrome?

Del Chiaro M, Mucelli RP, Blomberg J, Segersvärd R, Verbeke C.

Fam Cancer. 2014 Jun;13(2):227-9. doi: 10.1007/s10689-013-9696-x.

PMID:
24317685
32.

Diagnostic value of abdominal drainage in individual risk assessment of pancreatic fistula following pancreaticoduodenectomy.

Ansorge C, Nordin JZ, Lundell L, Strömmer L, Rangelova E, Blomberg J, Del Chiaro M, Segersvärd R.

Br J Surg. 2014 Jan;101(2):100-8. doi: 10.1002/bjs.9362. Epub 2013 Dec 5.

PMID:
24306817
33.

Computed tomography staging of pancreatic cancer: a validation study addressing interobserver agreement.

Loizou L, Albiin N, Ansorge C, Andersson M, Segersvärd R, Leidner B, Sundin A, Lundell L, Kartalis N.

Pancreatology. 2013 Nov-Dec;13(6):570-5. doi: 10.1016/j.pan.2013.09.004. Epub 2013 Oct 10.

PMID:
24280571
34.

Enucleation of branch duct-IPMN in a transplant patient.

Del Chiaro M, Albiin N, Segersvärd R.

Pancreatology. 2013 May-Jun;13(3):312-3. No abstract available.

PMID:
23858563
35.

Conservative treatment of chronic pancreatitis.

Löhr JM, Haas SL, Lindgren F, Enochsson L, Hedström A, Swahn F, Segersvärd R, Arnelo U.

Dig Dis. 2013;31(1):43-50. doi: 10.1159/000345720. Epub 2013 Jun 17. Review.

PMID:
23797122
36.

Impact of body mass index for patients undergoing pancreaticoduodenectomy.

Del Chiaro M, Rangelova E, Ansorge C, Blomberg J, Segersvärd R.

World J Gastrointest Pathophysiol. 2013 May 15;4(2):37-42. doi: 10.4291/wjgp.v4.i2.37.

37.

European experts consensus statement on cystic tumours of the pancreas.

Del Chiaro M, Verbeke C, Salvia R, Klöppel G, Werner J, McKay C, Friess H, Manfredi R, Van Cutsem E, Löhr M, Segersvärd R; European Study Group on Cystic Tumours of the Pancreas.

Dig Liver Dis. 2013 Sep;45(9):703-11. doi: 10.1016/j.dld.2013.01.010. Epub 2013 Feb 14.

PMID:
23415799
38.

Management of alcohol use disorders in patients with chronic pancreatitis.

Lang MB, Segersvärd R, Grundsten M, Segerdahl M, Arnelo U, Permert J, Franck J, Löhr M, Tsai JA.

JOP. 2012 Nov 10;13(6):654-9. doi: 10.6092/1590-8577/1037.

39.

Portal venous system thrombosis after pancreatic resection.

Ansari D, Ansorge C, Andrén-Sandberg A, Ansari D, Segersvärd R.

World J Surg. 2013 Jan;37(1):179-84. doi: 10.1007/s00268-012-1777-8.

PMID:
22965537
40.

Serum proteome profiling of pancreatitis using recombinant antibody microarrays reveals disease-associated biomarker signatures.

Sandström A, Andersson R, Segersvärd R, Löhr M, Borrebaeck CA, Wingren C.

Proteomics Clin Appl. 2012 Oct;6(9-10):486-96. doi: 10.1002/prca.201200051.

PMID:
22930578
41.

Identification of serum biomarker signatures associated with pancreatic cancer.

Wingren C, Sandström A, Segersvärd R, Carlsson A, Andersson R, Löhr M, Borrebaeck CA.

Cancer Res. 2012 May 15;72(10):2481-90. doi: 10.1158/0008-5472.CAN-11-2883.

42.
43.

Structured intraoperative assessment of pancreatic gland characteristics in predicting complications after pancreaticoduodenectomy.

Ansorge C, Strömmer L, Andrén-Sandberg Å, Lundell L, Herrington MK, Segersvärd R.

Br J Surg. 2012 Aug;99(8):1076-82. doi: 10.1002/bjs.8784. Epub 2012 May 4.

PMID:
22556164
44.

Optimising diffusion-weighted MR imaging for demonstrating pancreatic cancer: a comparison of respiratory-triggered, free-breathing and breath-hold techniques.

Kartalis N, Loizou L, Edsborg N, Segersvärd R, Albiin N.

Eur Radiol. 2012 Oct;22(10):2186-92. doi: 10.1007/s00330-012-2469-3. Epub 2012 May 2.

PMID:
22549106
45.

Preoperative pancreas CT/MRI characteristics predict fistula rate after pancreaticoduodenectomy.

Frozanpor F, Loizou L, Ansorge C, Segersvärd R, Lundell L, Albiin N.

World J Surg. 2012 Aug;36(8):1858-65. doi: 10.1007/s00268-012-1567-3.

PMID:
22450754
46.

Early intraperitoneal metabolic changes and protease activation as indicators of pancreatic fistula after pancreaticoduodenectomy.

Ansorge C, Regner S, Segersvärd R, Strömmer L.

Br J Surg. 2012 Jan;99(1):104-11. doi: 10.1002/bjs.7730. Epub 2011 Nov 3.

PMID:
22052299
47.

Validation of the harmless acute pancreatitis score in predicting nonsevere course of acute pancreatitis.

Oskarsson V, Mehrabi M, Orsini N, Hammarqvist F, Segersvärd R, Andrén-Sandberg A, Sadr Azodi O.

Pancreatology. 2011;11(5):464-8. doi: 10.1159/000331502. Epub 2011 Sep 29.

PMID:
21968430
48.

Pancreatic cancer cells expressing hypoxia-inducible factor-1α tend to be adjacent to intratumoral blood vessels.

Cheng BQ, Segersvärd R, Permert J, Wang F.

Eur Surg Res. 2010;45(3-4):134-7. doi: 10.1159/000319876. Epub 2010 Oct 1.

PMID:
20924188
49.

Impact of pancreatic gland volume on fistula formation after pancreatic tail resection.

Frozanpor F, Albiin N, Linder S, Segersvärd R, Lundell L, Arnelo U.

JOP. 2010 Sep 6;11(5):439-43.

50.

Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets.

Christoffersson G, Henriksnäs J, Johansson L, Rolny C, Ahlström H, Caballero-Corbalan J, Segersvärd R, Permert J, Korsgren O, Carlsson PO, Phillipson M.

Diabetes. 2010 Oct;59(10):2569-78. doi: 10.2337/db10-0205. Epub 2010 Jul 22.

Supplemental Content

Loading ...
Support Center